OCULATAX 50 MICROGRAMMI/ML Eye drops, solution
Запит на рецепт онлайн
Лікар розгляне ваш випадок і визначить, чи є рецепт медично доцільним.
Поговоріть з лікарем про ці ліки
Обговоріть симптоми та можливі подальші кроки під час короткої онлайн-консультації.
Інструкція із застосування OKULATAX
Зміст інструкції
OCULATAX
50 micrograms/ml eye drops, solution
Latanoprost
Read this leaflet carefully before you start using this medicine as it contains important
information for you.
- Keep this leaflet. You may need to read it again.
- If you have any questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not pass it on to others, even if their symptoms are the same as yours, as it could be harmful.
- If you get any side effects, even those not listed in this leaflet, tell your doctor or pharmacist. See section 4.
Contents of this leaflet:
- 1. What OCULATAX is and what it is used for
- 2. What you need to know before you use OCULATAX
- 3. How to use OCULATAX
- 4. Possible side effects
- 5. How to store OCULATAX
- 6. Contents of the pack and other information
1. What is OCULATAX and what is it used for
OCULATAX contains the active ingredient Latanoprost which belongs to the category of medicines known as
prostaglandin analogues. Latanoprost works by increasing the natural outflow of fluid
from inside the eye to the blood (blood flow).
OCULATAX is used to decrease the pressure inside the eye if you have a disease known as
open-angle glaucoma (damage to the optic nerve caused by a high increase in pressure inside
the eye) or if you suffer from increased internal eye pressure (ocular hypertension).
2. What you need to know before using OCULATAX
Do not use OCULATAX
- if you are allergic to the active substance or to any of the other ingredients of this medicine (listed in section 6).
- if you are a pregnant woman, planning a pregnancy or breastfeeding (see “Pregnancy and breastfeeding”).
Warnings and precautions
Talk to your doctor or pharmacist before using OCULATAX.
OCULATAX can be used in adult women and men (including the elderly). The use of
OCULATAX is not recommended for patients under 18 years of age.
Use OCULATAX with caution:
- if you have undergone or are going to undergo eye surgery (including cataract surgery, a condition due to the progressive loss of transparency of the lens located inside the eye, the crystalline lens);
- if you have eye pain, irritation or inflammation, blurred vision;
- if you suffer from dry eyes;
- if you suffer from severe or poorly controlled asthma;
- if you are a contact lens wearer. In this case, you can continue to take OCULATAX following the instructions in the “How to use OCULATAX” section.
- if you have suffered or are currently suffering from a viral eye infection caused by the herpes simplex virus (HSV).
- if you have risk factors for eye inflammation such as iritis and uveitis, or for a condition called cystoid macular edema.
OCULATAXcan cause a gradual change in the color of the eye, which may be permanent, due to
an increase in the amount of brown pigment in the colored part of the eye called the iris (See
“Possible side effects”).
A gradual change in the eyelashes of the treated eye and a change in the
hair around the treated eye have been observed (see “Possible side effects”).
Children and adolescents
OCULATAX is not recommended for children and adolescents under 18 years of age.
Other medicines and OCULATAX
Tell your doctor or pharmacist if you are taking, have recently taken or might take any
other medicines including medicines (or eye drops) without a prescription.
The use of OCULATAXtogether with other eye drops containing active ingredients similar to
latanoprost (prostaglandins, prostaglandin analogues or prostaglandin derivatives) is not recommended.
If you use OCULATAX together with eye drops containing the active ingredient timolol, the two eye drops must be
administered with an interval of at least 5 minutes between them.
Pregnancy and breastfeeding
If you are pregnant, suspect you are pregnant or are planning a pregnancy, or if you are breastfeeding with breast milk
ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
Do not use OCULATAX during pregnancy.
Breastfeeding
Do not use OCULATAX during breastfeeding.
Driving and using machines
When using OCULATAX you may experience temporary (transient) blurred vision. If this
happens, do not drive or use equipment or machinery until your vision is clear again.
OCULATAX contains benzalkonium chloride
Benzalkonium chloride can cause eye irritation. Avoid contact of the medicine with soft contact lenses.
Remove the contact lenses before application and wait at least 15 minutes before reinserting them.
The decolorizing action on soft contact lenses is known.
3. How to use OCULATAX
Use this medicine following the instructions of your doctor or pharmacist exactly. If you have any doubts
consult your doctor or pharmacist.
Recommended dose in adults (including elderly patients)
The recommended dose is one drop of OCULATAX once a day in the eye(s) to be treated.
Optimal effect is achieved by administering OCULATAX in the evening.
Do not instill OCULATAXmore than once a day, as more frequent administrations have been shown to decrease the effect of lowering eye pressure (hypotensive effect on intraocular pressure).
As with other eye drops, instill one drop into the eye and press with a finger on the inner corner of the affected eye.
Wait one minute keeping your eyes closed, continuing to hold down with your finger. This should be done immediately after instillation of each single drop.
Contact lens wearers
If you wear contact lenses, you must remove them before instilling the eye drops and you can reapply them after 15
minutes.
If you are using more than one medicine for the eyes for local use, administer them with an interval of at least
five minutes from each other.
If you use more OCULATAX than you should
In case of ingestion/accidental intake of an excessive dose of OCULATAX, immediately
inform your doctor or go to the nearest hospital.
If you put too many drops in your eyes, you may experience mild irritation, tearing and redness of the eyes.
These effects are transient, but still contact your doctor for advice.
If you forget to use OCULATAX
Do not use a double dose to make up for a missed dose.
If you forgot to use OCULATAX, continue to take the usual dose at the usual time.
If you stop using OCULATAX
If you have any doubts about the use of this medicine, consult your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
manifest.
Very common side effects(may affect more than 1 in 10 people):
- gradual alteration of the eye color due to the increase in the amount of brown pigment in the colored part of the eye called the iris. This change will be more likely if your eyes are of mixed color (blue - brown, gray-brown, yellow-brown or green-brown) rather than a uniform color (blue, gray, green or brown). Any change in eye color may occur even after years, although it generally appears within the first 8 months of treatment. The color change may be permanent and may be more noticeable if you use OCULATAX in only one eye. No problems have been found associated with the change in eye color. After stopping treatment with OCULATAX, no further change in eye color has been observed;
- red eyes;
- eye irritation (burning sensation, gritty sensation, itching, stinging sensation or foreign body sensation in the eyes);
- gradual alteration of the eyelashes of the treated eye and alteration of the fluff around the treated eye, observed mostly in people of Japanese origin. These changes include an
increase in the lengthening, thickening, darkening and thickening of the eyelashes or
of the fluff and the growth of eyelashes with abnormal orientation. Changes in eyelashes are
reversible with discontinuation of treatment.
Common side effects(may affect up to 1 in 10 people):
- irritation or abrasion of the eye surface;
- inflammation of the eyelid margin (blepharitis);
- eye pain;
- sensitivity to light (photophobia).
Uncommon side effects(may affect up to 1 in 100 people):
- swelling of the eyelids;
- dry eye;
- inflammation or irritation of the eye surface (keratitis);
- blurred vision;
- conjunctivitis;
- skin rash;
- nausea;
- vomiting.
Rare side effects(may affect up to 1 in 1000 people):
- inflammation of the eye (iritis/uveitis);
- swelling of the retina (macular edema);
- symptoms related to swelling or abrasion/damage to the eye surface, swelling of the area around the eyes (periorbital edema), altered orientation of the eyelashes or abnormal eyelash growth;
- skin reactions on the eyelids;
- darkening of the skin of the eyelids;
- asthma, worsening of asthma and shortness of breath (dyspnea).
Very rare side effects(may affect up to 1 in 10,000 people):
- worsening of angina (chest pain due to lack of oxygen to the heart) if you suffer from heart disease;
- chest pain;
- sunken appearance of the eye (hollowing of the eye socket).
The following have also been reported:
- fluid-filled area in the colored part of the eye (iris cyst);
- headache and dizziness;
- increased perception of heartbeats (palpitations);
- myalgia (muscle pain) and arthralgia (joint pain);
- development of a viral eye infection caused by the herpes simplex virus (HSV).
In very rare cases, some patients with severe damage to the transparent layer in the front of the eye (the
cornea) have developed cloud-like spots on the cornea due to calcium accumulation during
treatment.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. You can also report side effects directly through the national reporting system at http://www.agenziafarmaco.gov.it/it/responsabili. By reporting side effects
you can help provide more information on the safety of this medicine.
5. How to store OCULATAX
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the pack after Scad..
The expiry date refers to the last day of that month.
Store in a refrigerator (2-8°C), in the original package to protect the medicine from light.
After the first opening of the vial, store it at a temperature not exceeding 25°C and the medicine must be
used within 28 days; after this period, any remaining medicine must be discarded.
Record the date of first opening in the designated space on the pack.
Do not dispose of any medicine in wastewater or household waste. Ask your pharmacist how to dispose of
medicines you no longer use. This will help protect the environment.
6. Contents of the pack and other information
What OCULATAX contains
- The active substance is latanoprost. 1 ml of solution contains 50 micrograms of latanoprost.
- The other ingredients are: Benzalkonium chloride, Sodium chloride, Sodium dihydrogen phosphate monohydrate, Disodium hydrogen phosphate anhydrous, Water for injections.
Description of the appearance of OCULATAX and contents of the pack
Pack containing 1 bottle of 2.5 ml - Eye drops, solution.
Marketing Authorisation Holder
Bionativa S.p.A.
Via Raffaello 15
Loc. Sambuca V.P. - 50028 Florence
Italy
Manufacturer
Genetic S.p.A. – Contrada Canfora – 84084 Fisciano (SA)
This leaflet was last updated on
Не впевнені, чи підходить вам цей лікарський засіб?
Обговоріть симптоми та можливі варіанти лікування з лікарем онлайн.
Виникли питання під час прийому ліків?
Обговоріть свої симптоми та лікування з лікарем онлайн.
- Країна реєстрації
- Лікарська формаEye drops, solution, 50 MICROGRAMMI/ML
- Код АТХS01EE01
- Діюча речовина
- Потрібен рецептТак
- Виробник
- Ця інформація надана лише для ознайомлення і не є медичною порадою. Рішення щодо лікування завжди приймає лікар.
- Альтернативи до OKULATAXЛікарська форма: Emulsion eye drops, 50 ?g / mlДіюча речовина: ЛатанопростВиробник: SANTEN OYПотрібен рецептЛікарська форма: Eye drops, solution, 50 MICROGRAMMI/MLДіюча речовина: ЛатанопростВиробник: OMNIVISION ITALIA SRLПотрібен рецептЛікарська форма: Eye drops, solution, 0.005 %Діюча речовина: ЛатанопростПотрібен рецепт
Аналоги OKULATAX в інших країнах
Препарати з тією самою діючою речовиною, доступні в інших країнах.
Аналог OKULATAX у Іспанія
Аналог OKULATAX у Польща
Аналог OKULATAX у Україна
Лікарі онлайн щодо OKULATAX
Застосування, безпека та можливість призначення рецепта — за результатами медичної оцінки.
Отримайте рецепт на OKULATAX онлайн
Заповніть форму за 2 хвилини
Розкажіть про симптоми, історію хвороби та потрібний препарат.
Оберіть лікаря або ми призначимо
Оберіть спеціаліста або ми підберемо найближчого доступного лікаря.
Лікар розглядає ваш випадок
Зазвичай протягом 30 хвилин. Може ставити уточнювальні запитання в чаті.
Отримайте в будь-якій аптеці
Електронний рецепт надсилається на вашу пошту — дійсний по всій Польщі.
Часті запитання
OKULATAX потребує рецепта в Італія. Ви можете обговорити з лікарем онлайн, чи підходить цей лікарський засіб для вашої ситуації.
Діюча речовина у OKULATAX — Латанопрост. Це допомагає визначити препарати з тим самим складом, але під іншими торговими назвами.
OKULATAX виробляється компанією BIONATIVA S.P.A.. Назва бренду та упаковка можуть відрізнятися залежно від дистрибʼютора.
Лікарі, зокрема Сімейні лікарі, Психіатри, Дерматологи, Кардіологи, Ендокринологи, Гастроентерологи, Пульмонологи, Нефрологи, Ревматологи, Гематологи, Інфекціоністи, Алергологи, Геріатри, Педіатри, Онкологи, можуть оцінити доцільність застосування OKULATAX з урахуванням вашого стану та місцевих правил. Ви можете записатися на онлайн-консультацію, щоб обговорити симптоми та можливі подальші кроки.
Польща має добре розвинену систему охорони здоров'я у великих містах, таких як Варшава, Краків, Вроцлав і Гданськ. Аптеки широко доступні та працюють відповідно до чинного законодавства, забезпечуючи доступ до рецептурних препаратів.
Ви можете придбати OKULATAX у Варшаві, Кракові, Вроцлаві або Гданську в будь-якій аптеці за наявності дійсного рецепта.
Щоб отримати рецепт, ви можете скористатися Oladoctor:
Інші препарати з тією самою діючою речовиною (Латанопрост) включають KATIOLANTSE, DROPLATAN, GALAXIA. Вони можуть відрізнятися торговою назвою або формою випуску, але містять той самий терапевтичний компонент. Перед зміною або початком прийому нового препарату варто проконсультуватися з лікарем.
